🔎 Trials Near Me

Home › Triglycerides

Pag-aaral pangklinika para sa Triglycerides na nagre-recruit sa U.S.

9 pag-aaral para sa Triglycerides ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.

Mga lungsod na may pinakamaraming pag-aaral

Ayos sa estado

Mga pag-aaral na kamakailan lamang in-update

Opisyal na teksto ng pag-aaral (English)

A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia

Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07269210

Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis

Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06880770

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

Nagre-recruitPhase 1
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07491172

A Study to Assess the Safety, Tolerability and Efficacy of ION775

Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07604974

Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol

Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07028749

Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT06822790

Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia

Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hul 17, 2026 · NCT06451770

A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol

Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 6, 2025 · NCT07199309

Differential Thrombogenesis by EPA and DHA Mediated by HDL

Nagre-recruitMaagang Phase 1
Edad 18 hanggang 69 · Lahat ng kasarian · Na-update Okt 1, 2025 · NCT06494488

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.